Successful Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in a Severe Combined Immune Deficiency Patient: a First Report

J Clin Immunol. 2016 Jul;36(5):437-40. doi: 10.1007/s10875-016-0293-2. Epub 2016 May 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Cyclophosphamide / therapeutic use*
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infant
  • Infant, Newborn
  • Severe Combined Immunodeficiency / immunology
  • Severe Combined Immunodeficiency / therapy*
  • Transplantation Conditioning
  • Transplantation, Haploidentical*

Substances

  • Immunosuppressive Agents
  • Cyclophosphamide